DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Sodium channel blockers - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sodium Channel Blockers - Pipeline Insight, 2022” report provides comprehensive insights about 30+ companies and 30+ pipe...
January 2022
60 pages
Soft Tissue Defect - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Soft Tissue Defect - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
Soft Tissue Neoplasms - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Soft Tissue Neoplasms - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Spain Healthcare Outlook Report, 2022
US$ 1,995.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Spain Healthcare Outlook 2022,” report provides comprehensive insights about healthcare scenario, regulatory policies and...
January 2022
60 pages
Spastic Cerebral Palsy - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Spastic Cerebral Palsy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Spinal Fusion - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Spinal Fusion - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historic...
January 2022
60 pages
Spinal Trauma Devices - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Spinal Trauma Devices - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Spinocerebellar Ataxias - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Spinocerebellar Ataxias - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
Spleen tyrosine kinase inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Spleen tyrosine kinase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies an...
January 2022
60 pages
SScILD - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'SScILD - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and...
January 2022
60 pages
Staphylococcal Infections - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Staphylococcal Infections - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Stargardt Disease (STGD) - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Stargardt Disease (STGD) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
STAT Inhibitors - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 2-3 working days DelveInsight’s, “STAT Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companies and 25+ pipe...
January 2022
90 pages
Status Epilepticus - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Status Epilepticus - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...
January 2022
60 pages
Stem Cell Mobilization - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Stem Cell Mobilization - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Sternal Wound Infection - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Sternal Wound Infection - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
